ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JULIAN ARANA MD

2695 LE JEUNE ROAD SUITE 300

Coral gables | Florida | 33134

(305) 441-9120

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,945Medicare Part D Prescriptions Filled, Including Refills

Rank: 258 out of 3647

$704K Total Retail Price of All Prescriptions

Rank: 550 out of 3647

663 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 663 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 663 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 18,198 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 957 937 1 3
SIMVASTATIN 676 668 2 1
AMLODIPINE BESYLATE 569 551 3 2
METOPROLOL SUCCINATE 547 531 4 18
METFORMIN HCL 503 490 5 6
TEMAZEPAM 490 454 6 47
LISINOPRIL 461 426 7 4
HYDROCHLOROTHIAZIDE 451 447 8 9
PRAVASTATIN SODIUM 431 425 9 16
LEVOTHYROXINE SODIUM 409 409 10 5
ALENDRONATE SODIUM 380 377 11 23
LOSARTAN POTASSIUM 375 350 12 11
ATENOLOL 353 333 13 10
ATORVASTATIN CALCIUM 346 315 14 13
CLORAZEPATE DIPOTASSIUM 312 310 10 15 200
ENALAPRIL MALEATE 272 272 16 35
GLIMEPIRIDE 264 262 17 45
RANITIDINE HCL 263 254 18 29
FENOFIBRATE 259 259 19 50
ALPRAZOLAM 252 236 20 31
CITALOPRAM HBR 236 236 21 25
WARFARIN SODIUM 231 231 22 15
FUROSEMIDE 216 213 23 8
LACTULOSE 192 192 24 128
LOSARTAN-HYDROCHLOROTHIAZIDE 192 192 24 48
AMLODIPINE BESYLATE-BENAZEPRIL 192 174 24 74
METOPROLOL TARTRATE 189 176 27 7
IRBESARTAN 181 175 28 232
SYNTHROID 170 158 29 42
CRESTOR 169 141 30 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 163 150 31 36
TAMSULOSIN HCL 162 162 32 28
LORAZEPAM 149 149 33 73
FLUTICASONE PROPIONATE 149 132 33 32
BENICAR HCT 147 147 35 165
ALLOPURINOL 141 140 36 37
PANTOPRAZOLE SODIUM 135 125 37 38
PAROXETINE HCL 134 121 38 60
FOLIC ACID 124 123 39 95
CLONAZEPAM 111 101 40 146
FLUOXETINE HCL 109 102 41 68
ZOLPIDEM TARTRATE 108 108 42 14
ESCITALOPRAM OXALATE 107 106 43 65
BENAZEPRIL HCL 105 105 44 71
PROAIR HFA 99 88 45 62
DIGOXIN 98 98 46 51
GABAPENTIN 97 93 47 17
CLOPIDOGREL 96 89 48 26
CIALIS 95 92 49 179
DIOVAN 93 93 50 40
MELOXICAM 93 93 50 33
CARVEDILOL 93 81 50 20
VOLTAREN 88 83 53 102
BENICAR 85 85 54 114
CLOTRIMAZOLE-BETAMETHASONE 84 68 55 84
PLAVIX 84 81 55 39
IBUPROFEN 84 80 55 55
DIAZEPAM 82 82 58 214
AZITHROMYCIN 82 78 58 34
ADVAIR DISKUS 82 63 58 52
POTASSIUM CHLORIDE 81 81 61 24
LORATADINE 79 76 62 109
DICYCLOMINE HCL 78 74 63 194
DONEPEZIL HCL 75 75 64 30
LABETALOL HCL 74 62 65 172
LANSOPRAZOLE 73 70 66 116
NEXIUM 73 71 66 44
BISOPROLOL-HYDROCHLOROTHIAZIDE 72 72 68 183
NAPROXEN 70 65 69 70
LOVASTATIN 69 69 70 21
SERTRALINE HCL 66 66 71 27
HYDROCODONE-ACETAMINOPHEN 66 66 S3 71 12
CYANOCOBALAMIN INJECTION 65 65 73 384
ONGLYZA 61 61 74 238
MECLIZINE HCL 61 61 74 85
JANUVIA 58 58 76 72
GLIPIZIDE 54 54 77 41
BETAMETHASONE DIPROPIONATE 54 48 77 311
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.